X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Piramal Healthcare with Aventis Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PIRAMAL ENTERPRISES vs SANOFI INDIA - Comparison Results

PIRAMAL ENTERPRISES    Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

SANOFI INDIA 
   Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PIRAMAL ENTERPRISES SANOFI INDIA PIRAMAL ENTERPRISES/
SANOFI INDIA
 
P/E (TTM) x 38.2 31.0 123.3% View Chart
P/BV x 3.8 5.5 69.6% View Chart
Dividend Yield % 0.6 1.6 38.7%  

Financials

 PIRAMAL ENTERPRISES   SANOFI INDIA
EQUITY SHARE DATA
    PIRAMAL ENTERPRISES
Mar-16
SANOFI INDIA
Dec-16
PIRAMAL ENTERPRISES/
SANOFI INDIA
5-Yr Chart
Click to enlarge
High Rs1,0654,560 23.4%   
Low Rs8054,400 18.3%   
Sales per share (Unadj.) Rs383.01,028.5 37.2%  
Earnings per share (Unadj.) Rs55.1129.0 42.7%  
Cash flow per share (Unadj.) Rs74.1186.0 39.8%  
Dividends per share (Unadj.) Rs17.5068.00 25.7%  
Dividend yield (eoy) %1.91.5 123.3%  
Book value per share (Unadj.) Rs719.9753.6 95.5%  
Shares outstanding (eoy) m172.5623.03 749.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.44.4 56.0%   
Avg P/E ratio x17.034.7 48.9%  
P/CF ratio (eoy) x12.624.1 52.4%  
Price / Book Value ratio x1.35.9 21.8%  
Dividend payout %31.852.7 60.2%   
Avg Mkt Cap Rs m161,344103,174 156.4%   
No. of employees `0003.83.6 104.4%   
Total wages/salary Rs m16,8983,592 470.4%   
Avg. sales/employee Rs Th17,472.66,537.7 267.3%   
Avg. wages/employee Rs Th4,466.9991.4 450.5%   
Avg. net profit/employee Rs Th2,512.8819.8 306.5%   
INCOME DATA
Net Sales Rs m66,09923,686 279.1%  
Other income Rs m2,425708 342.5%   
Total revenues Rs m68,52424,394 280.9%   
Gross profit Rs m18,7235,281 354.5%  
Depreciation Rs m3,2741,313 249.4%   
Interest Rs m9,38815 62,584.7%   
Profit before tax Rs m8,4854,661 182.0%   
Minority Interest Rs m30-   
Prior Period Items Rs m1,5930-   
Extraordinary Inc (Exp) Rs m4570-   
Tax Rs m1,0321,691 61.0%   
Profit after tax Rs m9,5062,970 320.1%  
Gross profit margin %28.322.3 127.0%  
Effective tax rate %12.236.3 33.5%   
Net profit margin %14.412.5 114.7%  
BALANCE SHEET DATA
Current assets Rs m47,48815,673 303.0%   
Current liabilities Rs m104,3626,678 1,562.8%   
Net working cap to sales %-86.038.0 -226.6%  
Current ratio x0.52.3 19.4%  
Inventory Days Days4176 53.4%  
Debtors Days Days5122 229.2%  
Net fixed assets Rs m26,5328,098 327.6%   
Share capital Rs m345230 149.8%   
"Free" reserves Rs m114,02417,088 667.3%   
Net worth Rs m124,22117,356 715.7%   
Long term debt Rs m75,8120-   
Total assets Rs m308,35625,400 1,214.0%  
Interest coverage x1.9311.7 0.6%   
Debt to equity ratio x0.60-  
Sales to assets ratio x0.20.9 23.0%   
Return on assets %6.111.8 52.1%  
Return on equity %7.717.1 44.7%  
Return on capital %10.026.9 37.0%  
Exports to sales %17.224.5 70.2%   
Imports to sales %6.628.0 23.6%   
Exports (fob) Rs m11,3625,801 195.9%   
Imports (cif) Rs m4,3646,627 65.9%   
Fx inflow Rs m14,4357,145 202.0%   
Fx outflow Rs m5,1836,846 75.7%   
Net fx Rs m9,253299 3,094.6%   
CASH FLOW
From Operations Rs m-67,7733,226 -2,100.8%  
From Investments Rs m-8,768-1,555 563.8%  
From Financial Activity Rs m76,199-1,818 -4,191.3%  
Net Cashflow Rs m-342-147 232.9%  

Share Holding

Indian Promoters % 52.9 0.0 -  
Foreign collaborators % 0.0 60.4 -  
Indian inst/Mut Fund % 4.0 14.4 27.8%  
FIIs % 26.6 14.6 182.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 16.5 10.5 157.1%  
Shareholders   93,274 15,184 614.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PIRAMAL ENTERPRISES With:   CADILA HEALTHCARE  TTK HEALTHCARE  SHASUN PHARMA  DISHMAN PHARMA  J.B.CHEMICALS  

Compare PIRAMAL ENTERPRISES With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Strong Note; Tata Global Beverages Surges 8.3%(Closing)

Indian share markets snapped their losing streak of last week and finished the trading day on a strong note due to strong buying momentum in FMCG stocks, metal stocks and auto stocks.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PIRAMAL ENTERPRISES SHARE PRICE


Aug 16, 2017 (Close)

TRACK PIRAMAL ENTERPRISES

  • Track your investment in PIRAMAL ENTERPRISES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PIRAMAL ENTERPRISES

PIRAMAL ENTERPRISES - FULFORD INDIA COMPARISON

COMPARE PIRAMAL ENTERPRISES WITH

MARKET STATS